Galderma Group AG (SWX:GALD)

Market Cap	35.02B
Revenue (ttm)	3.73B
Net Income (ttm)	300.62M
Shares Out	237.41M
EPS (ttm)	1.26
PE Ratio	116.68
Forward PE	44.92
Dividend	0.15 (0.10%)
Ex-Dividend Date	n/a

Volume	88,479
Average Volume	1,512,154
Open	149.10
Previous Close	147.50
Day's Range	147.40 - 149.40
52-Week Range	72.70 - 150.20
Beta	n/a
RSI	63.36
Earnings Date	Oct 31, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 6,545
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: GALD

Financial Performance

Financial numbers in USD